Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 22 Nov 2024

The combination of Mycobacterium tuberculosis fusion proteins LT33 and LT28 induced strong protective immunity in mice

in Vaccines and Molecular Therapeutics

Pu He
Juan Wang
Daquan Tan
Lina Hu
Yanlin Ma
Youjun Mi
Fei Li
Tingting Zhang
Yunjie Du
Wenhua Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450124

1,225 views

Original Research

Published on 21 Nov 2024

Immunoinformatic design of a multivalent vaccine against Brucella abortus and its evaluation in a murine model using a DNA prime-protein boost strategy

in Vaccines and Molecular Therapeutics

Raúl E. Molina
Alberto Osorio
Manuel Flores-Concha
Leonardo A. Gómez
Ilse Alvarado
Italo Ferrari
Angel Oñate

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456078

659 views

Original Research

Published on 21 Nov 2024

mRNA-based platform for preventing and treating Staphylococcus aureus by targeted staphylococcal enterotoxin B

in Vaccines and Molecular Therapeutics

Fumei Luo
Chuanfei Xu
Chengwen Zhang
Aomo Tan
Dongshui Lu
Ping Luo
Ping Cheng
Weijun Zhang
Lijuan Bai
Cuiyun Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490044

1,223 views

Original Research

Published on 20 Nov 2024

B-cell dynamics underlying poor response upon split-inactivated influenza virus vaccination

in Vaccines and Molecular Therapeutics

Laise Rodrigues Reis
Vanessa Silva-Moraes
Andréa Teixeira-Carvalho
Ted M. Ross

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481910

1,088 views

Review

Published on 20 Nov 2024

Analysis of immunogenicity and purification methods in conjugated polysaccharide vaccines: a new approach in fighting pathogenic bacteria

in Vaccines and Molecular Therapeutics

Arya Sheikhi
Mina Shirmohammadpour
Nima Mahdei Nasirmahalleh
Bahman Mirzaei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483740

1,038 views

Systematic Review

Published on 19 Nov 2024

A bibliometric analysis of immunotherapy for atherosclerosis: trends and hotspots prediction

in Vaccines and Molecular Therapeutics

Jing-Hui Wang
Guan-Rui Pan
Long Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1493250

1,007 views

Original Research

Published on 19 Nov 2024

Cocktail vaccine for the management of Hyalomma anatolicum and Rhipicephalus microplus

in Vaccines and Molecular Therapeutics

Haranahally Vasanthachar Manjunathachar
Binod Kumar
Balasamudram Chandrasekhar Parthasarathi
Gajanan M. Chigure
Buddhi Chandrasekaran Saravanan
Muthu Sankar
Darasaguppe Ramachandra Harish
José de la Fuente
Srikanta Ghosh

Frontiers in Immunology

doi 10.3389/fimmu.2024.1471317

976 views

Case Report

Published on 19 Nov 2024

Case report: Satralizumab therapy for bilateral refractory optic neuritis following the first dose of bivalent human papilloma virus vaccine

in Vaccines and Molecular Therapeutics

Chuanbin Sun

Frontiers in Immunology

doi 10.3389/fimmu.2024.1499045

792 views

Original Research

Published on 18 Nov 2024

In silico analysis for the development of multi-epitope vaccines against Mycobacterium tuberculosis

in Vaccines and Molecular Therapeutics

Jin-Seung Yun
A Reum Kim
Soo Min Kim
Eunkyung Shin
Sang-Jun Ha
Dokeun Kim
Hye-Sook Jeong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1474346

1,308 views

Original Research

Published on 13 Nov 2024

Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study

in Vaccines and Molecular Therapeutics

Nayab Batool Rizvi
Maryam Bibi
Muhmmad Zeeshan Rana
Sehrish Zaffar
Hassam Farooq

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448408

3,362 views

Original Research

Published on 11 Nov 2024

Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis

in Vaccines and Molecular Therapeutics

Mohamed A. Kamal
Matthew P. Kosloski
Ching-Ha Lai
Michael A. Partridge
Manoj Rajadhyaksha
Vanaja Kanamaluru
Ashish Bansal
Arsalan Shabbir
Brad Shumel
Marius Ardeleanu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466372

1,981 views

Review

Published on 08 Nov 2024

Personalized cancer vaccine design using AI-powered technologies

in Vaccines and Molecular Therapeutics

Anant Kumar
Shriniket Dixit
Kathiravan Srinivasan
Dinakaran M
P. M. Durai Raj Vincent

Frontiers in Immunology

doi 10.3389/fimmu.2024.1357217

3,308 views

Review

Published on 07 Nov 2024

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination

in Vaccines and Molecular Therapeutics

Carla Nel
John Frater

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478703

1,463 views

Clinical Trial

Published on 07 Nov 2024

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China

in Vaccines and Molecular Therapeutics

Zhenzhen Liang
Xu Chen
Bo Xing
Xiaosong Hu
Miaomiao Liu
Xinpei Zhang
Yugang Shen
Yan Wang
Yingping Chen
Huakun Lv

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444686

922 views

Original Research

Published on 06 Nov 2024

Determination of immunogenicity of an inactivated ND-vaccine developed experimentally with Newcastle disease virus (Genotype VII.2) local isolates of Bangladesh

in Vaccines and Molecular Therapeutics

Mohammad Aynul Haque
Md. Enamul Haque
Mst. Kohinoor Parvin
Md. Mostofa Kamal
Tanbin Rubaiya Islam
Mohammad Sadekuzzaman
Md. Ariful Islam
Mst. Minara Khatun
Muhammad Tofazzal Hossain
Mohammad Asir Uddin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1482314

741 views

Original Research

Published on 06 Nov 2024

Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12–2023.4 wave of the COVID-19 pandemic

in Vaccines and Molecular Therapeutics

Rongrong Dai
Weiyu Peng
Nani Xu
Pan Qin
Linling Ding
Qianhui Hua
Jianmin Jiang
Fang He
Hangjie Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476186

992 views

Navigation group

Articles

The combination of Mycobacterium tuberculosis fusion proteins LT33 and LT28 induced strong protective immunity in mice

Immunoinformatic design of a multivalent vaccine against Brucella abortus and its evaluation in a murine model using a DNA prime-protein boost strategy

mRNA-based platform for preventing and treating Staphylococcus aureus by targeted staphylococcal enterotoxin B

B-cell dynamics underlying poor response upon split-inactivated influenza virus vaccination

Analysis of immunogenicity and purification methods in conjugated polysaccharide vaccines: a new approach in fighting pathogenic bacteria

A bibliometric analysis of immunotherapy for atherosclerosis: trends and hotspots prediction

Cocktail vaccine for the management of Hyalomma anatolicum and Rhipicephalus microplus

Case report: Satralizumab therapy for bilateral refractory optic neuritis following the first dose of bivalent human papilloma virus vaccine

In silico analysis for the development of multi-epitope vaccines against Mycobacterium tuberculosis

Comparison of antibody responses of heterologous and homologous Covid-19 booster vaccination: an observational study

Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis

Personalized cancer vaccine design using AI-powered technologies

Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China

Determination of immunogenicity of an inactivated ND-vaccine developed experimentally with Newcastle disease virus (Genotype VII.2) local isolates of Bangladesh

Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12–2023.4 wave of the COVID-19 pandemic